fbpx

Blood Products

This page is due for revision.

OVERVIEW

  • important indications
  • doses
  • blood product compatibilities

IMPORTANT INDICATIONS

Packed red blood cells (PRBCs)

  • Hb <100 and high risk of myocardial ischemia
  • severe anemia (e.g. Hb<70)
  • major active bleeding and Hb<100

Platelets

  • <10
  • <20 and high risk (fever, neutropenia, antibiotics, risk of intracranial haemorrhage)
  • <50 and active bleeding or requires invasive procedure
  • <80 and requires neurosurgery or ophthalmic surgery
  • platelet function defects and bleeding (regardless of platelet count)

FFP

  • INR >1.5 and needs invasive procedure
  • INR >1.5 and actively bleeding (e.g. massive transfusion protocol, post-bypass surgery)

Cryoprecipitate

  • fibrinogen <1.0 and actively bleeding (e.g. massive transfusion protocol)
  • DIC
  • hereditary hypofibrinogenemia, haemophilia, von Willebrand disease

Prothrombin complex concentrate (PCC)

  • warfarin overdose (alternative to FFP)

Granulocyte concentrate

  • neutropenic sepsis

IV immunoglobulin

  • multiple — e.g. GBS, ITP, MG, vasculitis

Factor 7

  • consider for rescue therapy if ongoing haemorrhage despite correction of pH and temperature, blood products to correct coagulopathy and no clear surgical cause

DOSES IN PAEDIATRICS

  • Red Cells: 4ml X kg X Hb g/dL rise required. (1 unit/bag ~ 300mL)
  • Fresh frozen plasma: 10 – 20 ml/kg (1 bag ~ 230mL)
  • Cryoprecipitate: 5-10 ml/kg (1 bag ~ 20mL)
  • Platelets: 10ml/kg (1 unit ~ 60mL. 1 pooled bag = 5 units)
  • Tranexamic acid: 100mg/kg then 10mg/kg/hr
  • Factor 7: 90mcg/kg
  • Prothrombin (factor 9) complex: 1mL/kg (25units/kg)

BLOOD PRODUCT COMPATIBILITIES

  • For RBCs: O = universal donor;  AB positive = universal acceptor
  • For FFP: AB = universal donor
blood product compatibilities
  • RhD negative females of childbearing age should receive RhD negative products
  • RhD negative male recipients and post-menopausal females may be transfused with RhD positive blood products with the exception of patients known to have anti-D or on regular transfusion support.
blood product compatibilities

Introduction to ICU Series

CCC 700 6

Critical Care

Compendium

Chris is an Intensivist and ECMO specialist at The Alfred ICU, where he is Deputy Director (Education). He is a Clinical Adjunct Associate Professor at Monash University, the Lead for the  Clinician Educator Incubator programme, and a CICM First Part Examiner.

He is an internationally recognised Clinician Educator with a passion for helping clinicians learn and for improving the clinical performance of individuals and collectives. He was one of the founders of the FOAM movement (Free Open-Access Medical education) has been recognised for his contributions to education with awards from ANZICS, ANZAHPE, and ACEM.

His one great achievement is being the father of three amazing children.

On Bluesky, he is @precordialthump.bsky.social and on the site that Elon has screwed up, he is @precordialthump.

| INTENSIVE | RAGE | Resuscitology | SMACC

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.